KAZIA THERAPEUTICS-SPON ADR (KZIA)
US48669G1058 - ADR
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.66M | 5.24M | 7.36M | 21.09M | 1.26M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | 0.00 | 6.50M | 7.50M | |||
| Receivables | 3.90M | 3.90M | 90.98K | 84.36K | 1.35M | |||
| Other Current Assets | 591.00K | 1.63M | 2.00M | 1.72M | 537.31K | |||
| Total Current Assets | 6.14M | 10.77M | 9.45M | 29.39M | 10.65M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | N/A | N/A | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 15.40M | 17.27M | 19.14M | 22.00M | 12.41M | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | N/A | N/A | |||
| Total Non-Current Assets | 15.44M | 17.31M | 26.44M | 28.70M | 12.41M | |||
| TOTAL ASSETS | 21.59M | 28.09M | 35.89M | 58.09M | 23.06M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 634.00K | 1.80M | 1.84M | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 6.48M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 10.88M | 3.47M | 2.24M | 3.27M | 1.99M | |||
| Accounts Payable | 4.55M | 857.31K | 1.52M | 1.89M | 1.69M | |||
| Other Current Liabilities | 3.25M | 1.44M | 1.13M | 3.16M | 1.39M | |||
| Total Current Liabilities | 25.80M | 7.57M | 6.73M | 8.33M | 5.07M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 2.02M | 2.29M | 2.56M | 2.93M | 3.41M | |||
| Other Non-Current Liabilities | 3.79M | 6.18M | 8.33M | 8.98M | 457.90K | |||
| Total Non-Current Liabilities | 5.80M | 8.47M | 10.89M | 11.91M | 3.87M | |||
| TOTAL LIABILITIES | 31.60M | 16.03M | 17.61M | 20.24M | 8.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -110.91M | -84.66M | -65.35M | -42.45M | -34.66M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 101.64M | 97.45M | 84.48M | 80.29M | 48.78M | |||
| Other Shareholders' Equity | -750.00K | -741.79K | -852.04K | 10.68K | 8.81K | |||
| Shares Outstanding | 504.07K | 345.33K | 210.13K | 2.00M | 143.26K | |||
| Tangible Book Value per Share | -0.76 | -0.23 | -0.06 | 0.12 | 0.18 | |||
| Total Shareholders' Equity | -10.02M | 12.05M | 18.27M | 37.85M | 14.13M | |||
| TOTAL LIABILITIES AND EQUITY | 21.59M | 28.09M | 35.89M | 58.09M | 23.06M | |||
| Statistics | ||||||||
| Current Ratio | 0.24 | 1.42 | 1.40 | 3.53 | 2.10 | |||
| Return On Assets (ROA) | -124.06% | -72.87% | -69.70% | -14.50% | -54.06% | |||
| Return On Equity (ROE) | N/A | -169.83% | -136.88% | -22.25% | -88.26% | |||
All data in AUD , ROIC based on taxRate of 0.21